MedPath

陕西孙思邈高新制药有限公司

Ownership
-
Established
2014-09-28
Employees
-
Market Cap
-
Website
http://www.ssmgxzy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

146

NMPA:146

Drug Approvals

增光胶囊

Approval Number
国药准字Z20080458
Approval Date
Oct 13, 2023
NMPA

化痔片

Approval Number
国药准字Z20083192
Approval Date
Mar 29, 2023
NMPA

强肝片

Approval Number
国药准字Z20060401
Approval Date
Dec 10, 2021
NMPA

藿香清胃胶囊

Approval Number
国药准字Z20060398
Approval Date
Dec 10, 2021
NMPA

Magmesium Trisilicatis Talets

Product Name
三硅酸镁片
Approval Number
国药准字H61022539
Approval Date
Mar 18, 2021
NMPA

Metamizole Sodium Tablets

Product Name
安乃近片
Approval Number
国药准字H61020412
Approval Date
Jan 15, 2021
NMPA

Moroxydine Hydrochloride Tablets

Product Name
盐酸吗啉胍片
Approval Number
国药准字H61022542
Approval Date
Jan 15, 2021
NMPA

Rifampicin Capsules

Product Name
利福平胶囊
Approval Number
国药准字H61021784
Approval Date
Jan 15, 2021
NMPA

Ibuprofen Tablets

Product Name
布洛芬片
Approval Number
国药准字H61021456
Approval Date
Jan 15, 2021
NMPA

Piperazine Phosphate Tablets

Product Name
磷酸哌嗪片
Approval Number
国药准字H61021460
Approval Date
Jan 15, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 15
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.